-The Hindu All govt departs and ministries have been asked to provide electronic options for all payments and receipts by March 31, 2016. The Prime Minister’s Office has set an ambitious target to shift at least 90% of all government transactions that involve payments or receipts from citizens and businesses to electronic or paperless mode by the end of 2016, replacing the use of cash, demand drafts, cheques and challans in government...

-The Financial Express The perennial gap between allocation of grain meant for the public distribution system by the Food Corporation of India, the principal procurement agency, and the lifting of such grains The perennial gap between allocation of grain meant for the public distribution system by the Food Corporation of India, the principal procurement agency, and the lifting of such grains by the states has narrowed considerably in recent months, reports Sandip...

-The Hindu The restrictions on private vehicle usage may have got most of the media coverage, but are by no means the only steps the government has announced. Nationally, over 35 per cent of urban households own a motorised two-wheeler and just under 10 per cent own a car, jeep or van. In Delhi, where per capita incomes are among the highest in the country, these proportions are much higher: nearly 40...

In a recent Gazette notification, the Government of India has removed the controversial provisions made in the PDS Control Order that was issued in March, 2015. This means that no more there will be a ceiling placed on the number of Antyodaya cards issued by any state.   The earlier order, which was issued by the Ministry of Consumer Affairs, Food and Public Distribution on 20 March, 2015, says that "when...

-The Times of India NEW DELHI: In a move that comes as a huge relief to patients of chronic Hepatitis C, the apex committee of the Central Drugs Standard Control Organisation (CDSCO) has granted a waiver of local trials for crucial new direct-acting antiviral drugs treating the disease. The waiver for sofosbuvir and ledipasvir co-formulation and for daclatasvir is expected to bring the generic version of these drugs, which cost a fraction...